Non‐fatal MI · patients with coronary heart disease
Psychological intervention with or without other rehabilitation showed no clear difference in non‐fatal MI compared with control (usual care/other rehabilitation) (low certainty).
1 finding from 1 review
Revascularisation (CABG and PCI combined) · patients with coronary heart disease
Psychological intervention with or without other rehabilitation showed no clear difference in revascularisation (CABG and PCI combined) compared with control (usual care/other rehabilitation) (moderate certainty).
1 finding from 1 review
Anxiety · patients with coronary heart disease
1 finding from 1 review
Depression · patients with coronary heart disease
1 finding from 1 review
Stress 1 month · patients with coronary heart disease
1 finding from 1 review
Stroke · patients with hypertension
Enalapril plus folic acid leads to lower stroke compared with enalapril (high certainty).
1 finding from 1 review
First unstable angina pectoris episode requiring hospitalisation · patients with hypertension
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Death from any cause · patients with hypertension
Enalapril plus folic acid showed no clear difference in death from any cause compared with enalapril (high certainty).
1 finding from 1 review
Serious adverse event (cancer) · patients with hypertension
Enalapril plus folic acid showed no clear difference in serious adverse event (cancer) compared with enalapril (moderate certainty).
1 finding from 1 review
Myocardial infarction · patients with hypertension
Enalapril plus folic acid showed no clear difference in myocardial infarction compared with enalapril (moderate certainty).
1 finding from 1 review
Percentage of time within the therapeutic range · oral anticoagulant therapy in patients with atrial fibrillation
1 finding from 1 review
Anxiety · oral anticoagulant therapy in patients with atrial fibrillation
1 finding from 1 review
Depression Measured after 52 weeks HADS depression score, 0‐21 points Low score means fewer symptoms · oral anticoagulant therapy in patients with atrial fibrillation
1 finding from 1 review
Decisional conflict · oral anticoagulant therapy in patients with atrial fibrillation
1 finding from 1 review
All‐cause mortality · heart failure in patients with Chagas cardiomyopathy
It is very uncertain whether carvedilol changes all‐cause mortality compared with placebo (very low certainty).
1 finding from 1 review
Time to heart decompensation · chronic heart failure in Chagas cardiomyopathy patients
1 finding from 1 review
Disease‐free period at 30, 60 and 90 days · chronic heart failure in Chagas cardiomyopathy patients
1 finding from 1 review
Quality of life · chronic heart failure in Chagas cardiomyopathy patients
1 finding from 1 review
Adverse events · chronic heart failure in Chagas cardiomyopathy patients
1 finding from 1 review
Hospital readmissions (heart failure‐ or adverse event‐related) · chronic heart failure in Chagas cardiomyopathy patients
1 finding from 1 review